Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive-stage Small Cell Lung Cancer (ES-SCLC)”

143 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 143 results

Testing effectiveness (Phase 2)Looking for participantsNCT07425795
What this trial is testing

Tislelizumab Combined With Chemotherapy Followed by Thoracic Consolidation Radiotherapy in the First-line Treatment of Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Chongqing University Cancer Hospital 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07061535
What this trial is testing

Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)Extensive Stage Lung Small Cell CancerExtensive-Stage Small-Cell Lung Cancer+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 40
Early research (Phase 1)Ended earlyNCT04422210
What this trial is testing

A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).

Who this might be right for
Small Cell Lung Cancer
Hoffmann-La Roche 2
Testing effectiveness (Phase 2)UnknownNCT05092412
What this trial is testing

Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Who this might be right for
Lung CancerExtensive-stage Small-cell Lung CancerDurvalumab
You Lu 30
Testing effectiveness (Phase 2)Looking for participantsNCT06758700
What this trial is testing

Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)Thoracic NeoplasmsLung Neoplasms+1 more
Shanghai Pulmonary Hospital, Shanghai, China 15
Testing effectiveness (Phase 2)Study completedNCT00616109
What this trial is testing

Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
University of Michigan Rogel Cancer Center 16
Early research (Phase 1)Study completedNCT03085849
What this trial is testing

SGI-110 Plus Durvalumab/Tremelimumab in SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Catherine Shu 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07022301
What this trial is testing

Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 Therapy

Who this might be right for
Small Cell Lung Cancer Extensive StageResistance to Immunotherapy
First Affiliated Hospital of Wannan Medical College 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT04334941
What this trial is testing

Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker

Who this might be right for
Extensive Stage Lung Small Cell Carcinoma
National Cancer Institute (NCI) 103
Testing effectiveness (Phase 2)Looking for participantsNCT07339059
What this trial is testing

Phase II Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer ( SCLC )Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Bindu R Potugari 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07459634
What this trial is testing

Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jazz Pharmaceuticals 50
Testing effectiveness (Phase 2)Study completedNCT00682981
What this trial is testing

A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Gemin X 218
Testing effectiveness (Phase 2)Study completedNCT00388960
What this trial is testing

Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Celgene 99
Testing effectiveness (Phase 2)Looking for participantsNCT06749691
What this trial is testing

Liposomal Irinotecan and Apatinib in ES-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, School of Medicine, Zhejiang University 30
Early research (Phase 1)Temporarily pausedNCT05403723
What this trial is testing

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

Who this might be right for
Extensive-stage Small-cell Lung Cancer
University of Maryland, Baltimore 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05280470
What this trial is testing

Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Daiichi Sankyo 187
Not applicableNot Yet RecruitingNCT07400575
What this trial is testing

Anlotinib in Cross-line Treatment of NSCLC and SCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)SCLC, Extensive Stage
Henan Cancer Hospital 350
Testing effectiveness (Phase 2)UnknownNCT04659785
What this trial is testing

Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Tianjin Medical University Second Hospital 53
Not applicableNot Yet RecruitingNCT06982287
What this trial is testing

A Retrospective Real-World Study on the Efficacy and Safety of Anlotinib Hydrochloride Combined With Immunotherapy Maintenance Therapy Following Standard Chemoimmunotherapy for ES-SCLC (ALTER-L059)

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Yong Fang 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04487756
What this trial is testing

Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Instituto Oncológico Dr Rosell 20
Load More Results